Associate Professor Deborah Young

Selected publications and creative works (Research Outputs)

  • Young, D., Fong, D. M., Lawlor, P. A., Wu, A., Mouravlev, A., McRae, M., ... During, M. J. (2014). Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy. Gene Ther, 21 (12), 1029-1040. 10.1038/gt.2014.82
    Other University of Auckland co-authors: Alexandre Mouravlev, Michelle Glass, Dahna Fong, Angela Wu
  • Kalev-Zylinska, M. L., Symes, W., Little, K. C. E., Sun, P., Wen, D., Qiao, L., ... Barber, P. A. (2013). Stroke patients develop antibodies that react with components of N-methyl-D-aspartate receptor subunit 1 in proportion to lesion size. Stroke, 44 (8), 2212-2219. 10.1161/STROKEAHA.113.001235
    URL: http://hdl.handle.net/2292/29192
    Other University of Auckland co-authors: Maggie Kalev-Zylinska, Alan Barber
  • Lawlor, P. A., Bland, R. J., Mouravlev, A. I., Young, D., & During, M. J. (2009). Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Molecular Therapy, 17 (10), 1692-1702.
    URL: http://hdl.handle.net/2292/14734
    Other University of Auckland co-authors: Alexandre Mouravlev
  • Jung, A. E., Fitzsimons, H. L., Bland, R. J., During, M. J., & Young, D. (2008). HSP70 and constitutively active HSF1 mediate protection against CDCrel-1-mediated toxicity. MOLECULAR THERAPY, 16 (6), 1048-1055. 10.1038/mt.2008.68
    URL: http://hdl.handle.net/2292/14732
  • Franich, N. R., Fitzsimons, H. L., Fong, D. M., Klugmann, M., During, M. J., & Young, D. (2008). AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. MOLECULAR THERAPY, 16 (5), 947-956. 10.1038/mt.2008.50
    URL: http://hdl.handle.net/2292/14731
    Other University of Auckland co-authors: Dahna Fong
  • Kaplitt, M. G., Feigin, A., Tang, C., Fitzsimons, H. L., Mattis, P., Lawlor, P. A., ... Eidelberg, D. (2007). Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. LANCET, 369 (9579), 2097-2105. 10.1016/S0140-6736(07)60982-9
    URL: http://hdl.handle.net/2292/14736
  • Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., ... Golde, T. E. (2007). Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal A beta levels. MOLECULAR NEURODEGENERATION, 210.1186/1750-1326-2-11
  • Mouravlev, A., Dunning, J., Young, D., & During, M. J. (2006). Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 103 (12), 4705-4710. 10.1073/pnas.0506137103
    URL: http://hdl.handle.net/2292/15697
    Other University of Auckland co-authors: Alexandre Mouravlev

Identifiers

Contact details

Primary location

M&HS BUILDING 502 - Bldg 502
Level 5, Room 501C
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand

Web links